0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fully MagLev Ventricular Assist Device (VAD) Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-32A18182
Home | Market Reports | Health| Medical Devices & Equipment
Global Fully MagLev Ventricular Assist Device VAD Market Research Report 2024
BUY CHAPTERS

Global Fully MagLev Ventricular Assist Device (VAD) Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-32A18182
Report
October 2025
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Fully MagLev Ventricular Assist Device (VAD) Market Size

The global Fully MagLev Ventricular Assist Device (VAD) market is projected to grow from US$ 1134 million in 2024 to US$ 2480 million by 2031, at a CAGR of 12.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Fully MagLev Ventricular Assist Device (VAD) Market

Fully MagLev Ventricular Assist Device (VAD) Market

A ventricular assist device (VAD) is a device that helps pump blood from the lower chambers of the heart to the rest of the body. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. The fully magnetic levitation VAD uses a fully magnetically levitated centrifugal pump, which has the advantages of small size, strong biocompatibility, and good infection risk prevention and control.
Currently, the global fully magnetic levitation ventricular assist device (VAD) market is monopolized by Abbott's HeartMate 3, which has now become the most commonly used left ventricular assist device (LVAD) in the world, with a market share of over 80%.
From the perspective of the global VAD device market, the main manufacturer in the United States is Abbott, and full magnetic levitation products have become the absolute mainstream. Competition in Europe is more intense, with more products approved earlier, but they are mainly used the second-generation technology (axial pump). The main player is Berlin heart CmbH.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Fully MagLev Ventricular Assist Device (VAD) market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Fully MagLev Ventricular Assist Device (VAD) Market Report

Report Metric Details
Report Name Fully MagLev Ventricular Assist Device (VAD) Market
Accounted market size in 2024 US$ 1134 in million
Forecasted market size in 2031 US$ 2480 million
CAGR 12.0%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Left Ventricular Assist Device (LVAD)
  • Biventricular Assist Device (BiVAD)
Segment by Application
  • Bridge-to-transplant (BTT)
  • Destination Therapy (DT)
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, BiVACOR, Suzhou Tongxin Medical Devices, Shenzhen Core Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Fully MagLev Ventricular Assist Device (VAD) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Fully MagLev Ventricular Assist Device (VAD) Market growing?

Ans: The Fully MagLev Ventricular Assist Device (VAD) Market witnessing a CAGR of 12.0% during the forecast period 2025-2031.

What is the Fully MagLev Ventricular Assist Device (VAD) Market size in 2031?

Ans: The Fully MagLev Ventricular Assist Device (VAD) Market size in 2031 will be US$ 2480 million.

Who are the main players in the Fully MagLev Ventricular Assist Device (VAD) Market report?

Ans: The main players in the Fully MagLev Ventricular Assist Device (VAD) Market are Abbott, BiVACOR, Suzhou Tongxin Medical Devices, Shenzhen Core Medical Technology

What are the Application segmentation covered in the Fully MagLev Ventricular Assist Device (VAD) Market report?

Ans: The Applications covered in the Fully MagLev Ventricular Assist Device (VAD) Market report are Bridge-to-transplant (BTT), Destination Therapy (DT), Others

What are the Type segmentation covered in the Fully MagLev Ventricular Assist Device (VAD) Market report?

Ans: The Types covered in the Fully MagLev Ventricular Assist Device (VAD) Market report are Left Ventricular Assist Device (LVAD), Biventricular Assist Device (BiVAD)

1 Study Coverage
1.1 Introduction to Fully MagLev Ventricular Assist Device (VAD): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Left Ventricular Assist Device (LVAD)
1.2.3 Biventricular Assist Device (BiVAD)
1.3 Market Segmentation by Application
1.3.1 Global Fully MagLev Ventricular Assist Device (VAD) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Bridge-to-transplant (BTT)
1.3.3 Destination Therapy (DT)
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Fully MagLev Ventricular Assist Device (VAD) Revenue Estimates and Forecasts 2020-2031
2.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales Estimates and Forecasts 2020-2031
2.4 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Fully MagLev Ventricular Assist Device (VAD) Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Left Ventricular Assist Device (LVAD) Market Size by Manufacturers
3.5.2 Biventricular Assist Device (BiVAD) Market Size by Manufacturers
3.6 Global Fully MagLev Ventricular Assist Device (VAD) Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Fully MagLev Ventricular Assist Device (VAD) Sales and Revenue by Type (2020-2031)
6.4 North America Fully MagLev Ventricular Assist Device (VAD) Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Fully MagLev Ventricular Assist Device (VAD) Sales and Revenue by Type (2020-2031)
7.4 Europe Fully MagLev Ventricular Assist Device (VAD) Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Fully MagLev Ventricular Assist Device (VAD) Sales and Revenue by Type (2020-2031)
9.4 Central and South America Fully MagLev Ventricular Assist Device (VAD) Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Fully MagLev Ventricular Assist Device (VAD) Product Models, Descriptions and Specifications
11.1.4 Abbott Fully MagLev Ventricular Assist Device (VAD) Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Fully MagLev Ventricular Assist Device (VAD) Sales by Product in 2024
11.1.6 Abbott Fully MagLev Ventricular Assist Device (VAD) Sales by Application in 2024
11.1.7 Abbott Fully MagLev Ventricular Assist Device (VAD) Sales by Geographic Area in 2024
11.1.8 Abbott Fully MagLev Ventricular Assist Device (VAD) SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 BiVACOR
11.2.1 BiVACOR Corporation Information
11.2.2 BiVACOR Business Overview
11.2.3 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Product Models, Descriptions and Specifications
11.2.4 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Sales by Product in 2024
11.2.6 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Sales by Application in 2024
11.2.7 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Sales by Geographic Area in 2024
11.2.8 BiVACOR Fully MagLev Ventricular Assist Device (VAD) SWOT Analysis
11.2.9 BiVACOR Recent Developments
11.3 Suzhou Tongxin Medical Devices
11.3.1 Suzhou Tongxin Medical Devices Corporation Information
11.3.2 Suzhou Tongxin Medical Devices Business Overview
11.3.3 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Product Models, Descriptions and Specifications
11.3.4 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Sales by Product in 2024
11.3.6 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Sales by Application in 2024
11.3.7 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Sales by Geographic Area in 2024
11.3.8 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) SWOT Analysis
11.3.9 Suzhou Tongxin Medical Devices Recent Developments
11.4 Shenzhen Core Medical Technology
11.4.1 Shenzhen Core Medical Technology Corporation Information
11.4.2 Shenzhen Core Medical Technology Business Overview
11.4.3 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Product Models, Descriptions and Specifications
11.4.4 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Sales by Product in 2024
11.4.6 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Sales by Application in 2024
11.4.7 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Sales by Geographic Area in 2024
11.4.8 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) SWOT Analysis
11.4.9 Shenzhen Core Medical Technology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Fully MagLev Ventricular Assist Device (VAD) Industry Chain
12.2 Fully MagLev Ventricular Assist Device (VAD) Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Fully MagLev Ventricular Assist Device (VAD) Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Fully MagLev Ventricular Assist Device (VAD) Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Fully MagLev Ventricular Assist Device (VAD) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Fully MagLev Ventricular Assist Device (VAD) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Fully MagLev Ventricular Assist Device (VAD) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Fully MagLev Ventricular Assist Device (VAD) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Fully MagLev Ventricular Assist Device (VAD) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Fully MagLev Ventricular Assist Device (VAD) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region (2020-2025) & (Units)
 Table 8. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Fully MagLev Ventricular Assist Device (VAD) Sales Share by Manufacturers (2020-2025)
 Table 12. Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Fully MagLev Ventricular Assist Device (VAD) Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Fully MagLev Ventricular Assist Device (VAD) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fully MagLev Ventricular Assist Device (VAD) as of 2024)
 Table 16. Global Fully MagLev Ventricular Assist Device (VAD) Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Fully MagLev Ventricular Assist Device (VAD) Average Selling Price (ASP) by Manufacturers (2020-2025) & (K US$/Unit)
 Table 18. Key Manufacturers Fully MagLev Ventricular Assist Device (VAD) Manufacturing Base and Headquarters
 Table 19. Global Fully MagLev Ventricular Assist Device (VAD) Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Type (2020-2025) & (Units)
 Table 23. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Type (2026-2031) & (Units)
 Table 24. Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Fully MagLev Ventricular Assist Device (VAD) ASP by Type (2020-2031) & (K US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Application (2020-2025) & (Units)
 Table 29. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Application (2026-2031) & (Units)
 Table 30. Fully MagLev Ventricular Assist Device (VAD) High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Fully MagLev Ventricular Assist Device (VAD) ASP by Application (2020-2031) & (K US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Fully MagLev Ventricular Assist Device (VAD) Growth Accelerators and Market Barriers
 Table 37. North America Fully MagLev Ventricular Assist Device (VAD) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Fully MagLev Ventricular Assist Device (VAD) Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Fully MagLev Ventricular Assist Device (VAD) Growth Accelerators and Market Barriers
 Table 40. Europe Fully MagLev Ventricular Assist Device (VAD) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Fully MagLev Ventricular Assist Device (VAD) Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Fully MagLev Ventricular Assist Device (VAD) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Fully MagLev Ventricular Assist Device (VAD) Investment Opportunities and Key Challenges
 Table 47. Central and South America Fully MagLev Ventricular Assist Device (VAD) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Abbott Corporation Information
 Table 51. Abbott Description and Major Businesses
 Table 52. Abbott Product Models, Descriptions and Specifications
 Table 53. Abbott Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 54. Abbott Sales Value Proportion by Product in 2024
 Table 55. Abbott Sales Value Proportion by Application in 2024
 Table 56. Abbott Sales Value Proportion by Geographic Area in 2024
 Table 57. Abbott Fully MagLev Ventricular Assist Device (VAD) SWOT Analysis
 Table 58. Abbott Recent Developments
 Table 59. BiVACOR Corporation Information
 Table 60. BiVACOR Description and Major Businesses
 Table 61. BiVACOR Product Models, Descriptions and Specifications
 Table 62. BiVACOR Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 63. BiVACOR Sales Value Proportion by Product in 2024
 Table 64. BiVACOR Sales Value Proportion by Application in 2024
 Table 65. BiVACOR Sales Value Proportion by Geographic Area in 2024
 Table 66. BiVACOR Fully MagLev Ventricular Assist Device (VAD) SWOT Analysis
 Table 67. BiVACOR Recent Developments
 Table 68. Suzhou Tongxin Medical Devices Corporation Information
 Table 69. Suzhou Tongxin Medical Devices Description and Major Businesses
 Table 70. Suzhou Tongxin Medical Devices Product Models, Descriptions and Specifications
 Table 71. Suzhou Tongxin Medical Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 72. Suzhou Tongxin Medical Devices Sales Value Proportion by Product in 2024
 Table 73. Suzhou Tongxin Medical Devices Sales Value Proportion by Application in 2024
 Table 74. Suzhou Tongxin Medical Devices Sales Value Proportion by Geographic Area in 2024
 Table 75. Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) SWOT Analysis
 Table 76. Suzhou Tongxin Medical Devices Recent Developments
 Table 77. Shenzhen Core Medical Technology Corporation Information
 Table 78. Shenzhen Core Medical Technology Description and Major Businesses
 Table 79. Shenzhen Core Medical Technology Product Models, Descriptions and Specifications
 Table 80. Shenzhen Core Medical Technology Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 81. Shenzhen Core Medical Technology Sales Value Proportion by Product in 2024
 Table 82. Shenzhen Core Medical Technology Sales Value Proportion by Application in 2024
 Table 83. Shenzhen Core Medical Technology Sales Value Proportion by Geographic Area in 2024
 Table 84. Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) SWOT Analysis
 Table 85. Shenzhen Core Medical Technology Recent Developments
 Table 86. Key Raw Materials Distribution
 Table 87. Raw Materials Key Suppliers
 Table 88. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 89. Milestones in Production Technology Evolution
 Table 90. Distributors List
 Table 91. Market Trends and Market Evolution
 Table 92. Market Drivers and Opportunities
 Table 93. Market Challenges, Risks, and Restraints
 Table 94. Research Programs/Design for This Report
 Table 95. Key Data Information from Secondary Sources
 Table 96. Key Data Information from Primary Sources


List of Figures
 Figure 1. Fully MagLev Ventricular Assist Device (VAD) Product Picture
 Figure 2. Global Fully MagLev Ventricular Assist Device (VAD) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Left Ventricular Assist Device (LVAD) Product Picture
 Figure 4. Biventricular Assist Device (BiVAD) Product Picture
 Figure 5. Global Fully MagLev Ventricular Assist Device (VAD) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Bridge-to-transplant (BTT)
 Figure 7. Destination Therapy (DT)
 Figure 8. Others
 Figure 9. Fully MagLev Ventricular Assist Device (VAD) Report Years Considered
 Figure 10. Global Fully MagLev Ventricular Assist Device (VAD) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Fully MagLev Ventricular Assist Device (VAD) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Fully MagLev Ventricular Assist Device (VAD) Revenue Market Share by Region (2020-2031)
 Figure 14. Global Fully MagLev Ventricular Assist Device (VAD) Sales (2020-2031) & (Units)
 Figure 15. Global Fully MagLev Ventricular Assist Device (VAD) Sales (CAGR) by Region (2020-2031) (Units)
 Figure 16. Global Fully MagLev Ventricular Assist Device (VAD) Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Fully MagLev Ventricular Assist Device (VAD) Sales Volume Market Share in 2024
 Figure 18. Global Fully MagLev Ventricular Assist Device (VAD) Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Left Ventricular Assist Device (LVAD) Revenue Market Share by Manufacturer in 2024
 Figure 21. Biventricular Assist Device (BiVAD) Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Fully MagLev Ventricular Assist Device (VAD) Sales Market Share by Type (2020-2031)
 Figure 23. Global Fully MagLev Ventricular Assist Device (VAD) Revenue Market Share by Type (2020-2031)
 Figure 24. Global Fully MagLev Ventricular Assist Device (VAD) Sales Market Share by Application (2020-2031)
 Figure 25. Global Fully MagLev Ventricular Assist Device (VAD) Revenue Market Share by Application (2020-2031)
 Figure 26. North America Fully MagLev Ventricular Assist Device (VAD) Sales YoY (2020-2031) & (Units)
 Figure 27. North America Fully MagLev Ventricular Assist Device (VAD) Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) in 2024
 Figure 29. North America Fully MagLev Ventricular Assist Device (VAD) Sales Volume (Units) by Type (2020- 2031)
 Figure 30. North America Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Fully MagLev Ventricular Assist Device (VAD) Sales Volume (Units) by Application (2020-2031)
 Figure 32. North America Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Fully MagLev Ventricular Assist Device (VAD) Sales YoY (2020-2031) & (Units)
 Figure 37. Europe Fully MagLev Ventricular Assist Device (VAD) Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Fully MagLev Ventricular Assist Device (VAD) Sales Volume (Units) by Type (2020-2031)
 Figure 40. Europe Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Fully MagLev Ventricular Assist Device (VAD) Sales Volume (Units) by Application (2020-2031)
 Figure 42. Europe Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 44. France Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales YoY (2020-2031) & (Units)
 Figure 49. Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Volume (Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Volume (Units) by Application (2020-2031)
 Figure 54. Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 59. India Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Fully MagLev Ventricular Assist Device (VAD) Sales YoY (2020-2031) & (Units)
 Figure 61. Central and South America Fully MagLev Ventricular Assist Device (VAD) Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Fully MagLev Ventricular Assist Device (VAD) Sales Volume (Units) by Type (2021-2031)
 Figure 64. Central and South America Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Fully MagLev Ventricular Assist Device (VAD) Sales Volume (Units) by Application (2020-2031)
 Figure 66. Central and South America Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Fully MagLev Ventricular Assist Device (VAD) Sales YoY (2020-2031) & (Units)
 Figure 70. Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales Volume (Units) by Type (2021-2031)
 Figure 73. South America Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales Volume (Units) by Application (2020-2031)
 Figure 75. Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Fully MagLev Ventricular Assist Device (VAD) Revenue (2020-2025) & (US$ Million)
 Figure 80. Fully MagLev Ventricular Assist Device (VAD) Industry Chain Mapping
 Figure 81. Regional Fully MagLev Ventricular Assist Device (VAD) Manufacturing Base Distribution (%)
 Figure 82. Global Fully MagLev Ventricular Assist Device (VAD) Production Market Share by Region (2020-2031)
 Figure 83. Fully MagLev Ventricular Assist Device (VAD) Production Process
 Figure 84. Regional Fully MagLev Ventricular Assist Device (VAD) Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart